Relation of the Glu298Asp polymorphism of the nitric oxide synthase gene to hypertension and serum cholesterol in Japanese workers

Preventive Medicine

Volumn 47, Issue 2, 2008, Pages 167-171

  Sawada, Tomoyo ^a   Kishimoto, Takuji ^a   Osaki, Yoneatsu ^a   Okamoto, Mikizoh ^a   Tahara, Aya ^a   Kaetu, Akihiko ^a   Kurosawa, Yoichi ^a   Kotani, Kazuhiko ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Blood pressure; Cholesterol; eNOS; Genetics; Polymorphism

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DNA POLYMORPHISM; FEMALE; GENDER; GENOTYPE; HUMAN; HYPERTENSION; JAPANESE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; CHOLESTEROL; FEMALE; GLUTAMIC ACID; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 47949114441     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2008.04.006     Document Type: Article

References (31)

1. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
2. Dosenko V.E., Zagoriy V.Y., Haytovich N.V., Gordok O.A., and Moibenko A.A. Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochim. Pol. 53 2 (2006) 299-302
3. Forstermann U. Endothelial NO synthase as a source of NO and superoxide. Eur. J. Clin. Pharmacol. 62 (2006) 5-12
4. Granath B., Taylor R.R., van Bockxmeer F.M., and Mamotte C.D. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J. Cardiovasc. Risk 8 4 (2001) 235-241
5. Hamajima N., Saito T., and Matsuo K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn. J. Cancer Res. 91 (2000) 865-868
6. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100 (1997) 2153-2157
7. Heltianu C., Costache G., Gafencu A., Diaconu M., Bodeanu M., Cristea C., Azibi K., Poenaru L., and Simionescu M. Relationship of eNOS gene variants to disease that have in common an endothelial cell dysfunction. J. Cell Mol. Med. 9 1 (2005) 135-142
8. James K.L., and Wee S.S. Oxidized low-density lipoprotein decrease the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270 1 (1995) 319-324
9. Jaramillo P.C., Muñoz M.A., Lanas M.C., Lanas Z.F., and Salazar L.A. Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clin. Chim. Acta 371 (2006) 102-106
10. Jia C.Q., Zhao Z.T., Wang L.H., Hao F.R., Feng Y.Q., Wang S.M., Xu X.F., and Jia C.X. Effects of G894T mutation in the endothelial nitric oxide synthase gene on blood pressure. Zhonghua Liu Xing Bing Xue Za Zhi 24 1 (2003) 36-39
11. Kader K.N., Akella R., Ziats N.P., Lakey L.A., Harasaki H., Ranieri J.P., and Bellamkonda R.V. eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro. Tissue Eng. 6 3 (2000) 241-251
12. Kato N., Sugiyama T., Morita H., Nabika T., Kurihara H., Yamori Y., and Yazaki Y. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 33 (1999) 933-936
13. Kawashima S. Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase / no synthase in atherosclerosis. J. Pharmacol. Sci. 96 (2004) 411-419
14. Kishimoto T., Misawa Y., Kaetu A., Nagai M., Osaki Y., Okamoto M., Yoshida S., Kurosawa Y., and Fukumoto S. eNOS Glu298Asp polymorphism and hypertension in a cohort study in Japanese. Prev. Med. 39 (2004) 927-931
15. Landmesser U., and Harrison D.G. Oxidant stress-a major cause of reduced endothelial nitric oxide availability in cardiovascular disease. Eur. J. Clin. Pharmacol. 62 (2006) 13-19
16. Letonja M. The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Caucasian women. Acta Cardiol. 59 6 (2004) 618-622
17. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., Tsui L.C., and Schappert K.T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268 23 (1993) 17478-17488
18. Milutinović A., and Hruskovicova H. The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men(Caucasians). Folia Biol. 51 (2005) 47-49
19. Miyamoto Y., Saito Y., Kajiyama N., Yoshimura M., Shimasaki Y., Nakayama M., Kamitani S., Harada M., Ishikawa M., Kuwahara K., Ogawa E., Hamanaka I., Takahashi N., Kaneshige T., Teraoka H., Akamizu T., Azuma N., Yoshimasa Y., Yoshimasa T., Itoh H., Masuda I., Yasue H., and Nakao K. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1998) 3-8
20. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., and Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric oxide 15 4 (2006) 265-279
21. Nitenberg A. Hypertension, endothelial dysfunction and cardiovascular risk. Arch. Mal. Coeur Vaiss. 99 10 (2006) 915-921
22. Ozaki M., Kawashima S., Yamashita T., Hirase T., Namiki M., Inoue N., Hirata K., Yasui H., Sakurai H., Yoshida Y., Masada M., and Yokoyama M. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Invest. 110 3 (2002) 311-340
23. Pereira A.C., Sposito A.C., Mota G.F., Cunha R.S., Herkenhoff F.L., Mill J.G., and Krieger J.E. Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure. Atherosclerosis 184 (2006) 193-200
24. Pereira T.V., Rudnicki M., Cheung B.M., Baum L., Yamada Y., Oliveira P.S., Pereira A.C., and Krieger J.E. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J. Hypertens. 25 (2007) 1763-1774
25. Tomasz J.G. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ. Res. 86 (2000) 85-90
26. Tsujita Y., Baba S., Yamauchi R., Mannami T., Kinoshita M., Yamamoto R., Katsuya T., Higaki J., Ogihara T., Ogata J., and Iwai N. Association analysis between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: the Suita Study. J. Hypertens. 19 11 (2001) 1941-1948
27. Wang C.L., Hsu L.A., Ko Y.S., Ko Y.L., and Lee Y.H. Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J. Formos. Med. Assoc. 100 11 (2001) 736-740
28. Wei D., Shan J., Chen Z., and Shi Y. The G894T mutation of the endothelial nitric oxide synthase gene is associated with coronary atherosclerotic heart disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19 6 (2002) 471-474
29. Wolff B., Grabe H.J., Schlüter C., Popowski K., Völzke H., Lüdemann J., John U., Felix S.B., and Cascorbi I. Endothelial nitric oxide synthase Glu298Asp gene polymorphism, blood pressure and hypertension in a general population sample. J. Hypertens. 23 7 (2005) 1361-1366
30. Yang Z., and Luscher T.F. Vascular endothelium. In: Lanzer P., and Topol E.J. (Eds). Pan Vascular Medicine (2002), Springer, Berlin 190-204 Heidelberg - New York
31. Zhao Q., Su S.Y., Chen S.F., Li B., and Gu D.F. Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin. Med. J. 119 13 (2006) 1065-1071